TY - JOUR
T1 - Exploiting protein cationization techniques in future drug development
AU - Futami, Junichiro
AU - Kitazoe, Midori
AU - Murata, Hitoshi
AU - Yamada, Hidenori
N1 - Funding Information:
The author thanks Nippon Shokubai Co. Ltd for collaborations about development of PEI-cationization technology. This work was in part supported by a research and development project of the Industrial Science and Technology Programme supported by the New Energy and Industrial Technology Development Organization (NEDO) and grants-in-aid from the Ministry of Education, Science and Culture of Japan (17360399 to H.Y.).
PY - 2007/2
Y1 - 2007/2
N2 - The development of a method for the efficient intracellular delivery of inherently non-permeable proteins is needed for manipulation of cellular phenotypes or the discovery of protein-based drugs. It has been demonstrated that proteins artificially cationized by chemical conjugation show efficient intracellular delivery via adsorptive-mediated endocytosis and then can exert their biological activity in cells. Studies have also revealed that cationic peptides known as cell-penetrating peptides (CPPs) provide a means to deliver molecules into mammalian cells. Although the internalization mechanisms remain controversial, it is now becoming clear that the main port of entry into cells by CPPs also involves adsorptive-mediated endocytosis rather than the direct penetration of the plasma membrane. As the mammalian cell membrane possesses an abundance of negatively charged glycoproteins and glycosphingolipids, cationization of proteins is a reasonable choice to endow them with the ability for intracellular delivery. Cationization of proteins is usually accompanied by drastic changes in protein properties, structure and biological activities. Recently developed sophisticated protein chemistry can minimize these side effects. Therefore, protein cationization techniques will hopefully prove to be powerful tools for innovative research and drug discovery. In this review, techniques for cationization of proteins and their intracellular delivery, as well as some of their potential therapeutic applications, are discussed.
AB - The development of a method for the efficient intracellular delivery of inherently non-permeable proteins is needed for manipulation of cellular phenotypes or the discovery of protein-based drugs. It has been demonstrated that proteins artificially cationized by chemical conjugation show efficient intracellular delivery via adsorptive-mediated endocytosis and then can exert their biological activity in cells. Studies have also revealed that cationic peptides known as cell-penetrating peptides (CPPs) provide a means to deliver molecules into mammalian cells. Although the internalization mechanisms remain controversial, it is now becoming clear that the main port of entry into cells by CPPs also involves adsorptive-mediated endocytosis rather than the direct penetration of the plasma membrane. As the mammalian cell membrane possesses an abundance of negatively charged glycoproteins and glycosphingolipids, cationization of proteins is a reasonable choice to endow them with the ability for intracellular delivery. Cationization of proteins is usually accompanied by drastic changes in protein properties, structure and biological activities. Recently developed sophisticated protein chemistry can minimize these side effects. Therefore, protein cationization techniques will hopefully prove to be powerful tools for innovative research and drug discovery. In this review, techniques for cationization of proteins and their intracellular delivery, as well as some of their potential therapeutic applications, are discussed.
KW - Chemical conjugation
KW - In-cell folding
KW - Polyethylenimine
KW - Protein engineering
KW - Protein transduction
UR - http://www.scopus.com/inward/record.url?scp=34447498405&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34447498405&partnerID=8YFLogxK
U2 - 10.1517/17460441.2.2.261
DO - 10.1517/17460441.2.2.261
M3 - Review article
C2 - 23496081
AN - SCOPUS:34447498405
SN - 1746-0441
VL - 2
SP - 261
EP - 269
JO - Expert Opinion on Drug Discovery
JF - Expert Opinion on Drug Discovery
IS - 2
ER -